GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) » Definitions » Return-on-Tangible-Asset

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) Return-on-Tangible-Asset : 0.00% (As of . 20)


View and export this data going back to 2001. Start your Free Trial

What is Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's annualized Net Income for the quarter that ended in . 20 was TND Mil. Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's average total tangible assets for the quarter that ended in . 20 was TND Mil. Therefore, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's annualized Return-on-Tangible-Asset for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Return-on-Tangible-Asset or its related term are showing as below:

XTUN:SIPHA's Return-on-Tangible-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.65
* Ranked among companies with meaningful Return-on-Tangible-Asset only.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Return-on-Tangible-Asset Historical Data

The historical data trend for Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Return-on-Tangible-Asset Chart

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Annual Data
Trend
Return-on-Tangible-Asset

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Semi-Annual Data
Return-on-Tangible-Asset

Competitive Comparison of Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Return-on-Tangible-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Return-on-Tangible-Asset falls into.


;
;

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Return-on-Tangible-Asset Calculation

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's annualized Return-on-Tangible-Asset for the fiscal year that ended in . 20 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=/( (+)/ )
=/
= %

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's annualized Return-on-Tangible-Asset for the quarter that ended in . 20 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is one times the annual (. 20) net income data.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T  (XTUN:SIPHA) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Business Description

Traded in Other Exchanges
N/A
Address
Fondouk Choucha, Ben Arous, TUN, 2013
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T is a Tunisia-based company mainly engaged in manufacturing and distributing medicines and drugs. The company also has its own research and development process to develop generic drugs. It offers pharmaceutical, dietary, hygiene, and cosmetic products in dry, liquid and pasty forms.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Headlines

No Headlines